Pharmacokinetic-pharmacodynamic model of magnesium sulfate in treatment of pregnancy-induced hypertensionCHEN GANG; LU JIAN-FENG; CAO WEN et al.Zhōngguó yàoli xuébào. 1991, Vol 12, Num 3, pp 222-225, issn 0253-9756, 4 p.Article

Midazolam pharmacokinetics and electroencephalographic changes in eight Chinese menLU JIAN-FENG; WU MAO-FU; CHEN GANG et al.Zhōngguó yàoli xuébào. 1993, Vol 14, Num 6, pp 485-488, issn 0253-9756Article

Development of a modeling framework to simulate efficacy endpoints for motesanib in patients with thyroid cancerCLARET, Laurent; LU, Jian-Feng; SUN, Yu-Nien et al.Cancer chemotherapy and pharmacology. 2010, Vol 66, Num 6, pp 1141-1149, issn 0344-5704, 9 p.Article

Absorption of SO₂ in aqueous solutions of mixed hydroxylammonium dicarboxylate ionic liquidsKUAN HUANG; LU, Jian-Feng; WU, You-Ting et al.Chemical engineering journal (1996). 2013, Vol 215-16, pp 36-44, issn 1385-8947, 9 p.Article

Clinical pharmacokinetics of bevacizumab in patients with solid tumorsLU, Jian-Feng; BRUNO, Rene; EPPLER, Steve et al.Cancer chemotherapy and pharmacology. 2008, Vol 62, Num 5, pp 779-786, issn 0344-5704, 8 p.Article

Population pharmacokinetics of trastuzumab in patients With HER2+ metastatic breast cancerBRUNO, Rene; WASHINGTON, Carla B; LU, Jian-Feng et al.Cancer chemotherapy and pharmacology. 2005, Vol 56, Num 4, pp 361-369, issn 0344-5704, 9 p.Article

Model-based analysis of the pharmacokinetic interactions between ritonavir, nelfinavir, and saquinavir after simultaneous and staggered oral administrationLU, Jian-Feng; BLASCHKE, Terrence F; FLEXNER, Charles et al.Drug metabolism and disposition. 2002, Vol 30, Num 12, pp 1455-1461, issn 0090-9556, 7 p.Article

Analyzing and removing SureSign watermarkLI LI; MA, Ying-Ying; CHANG, Chin-Chen et al.Signal processing. 2013, Vol 93, Num 5, pp 1374-1378, issn 0165-1684, 5 p.Article

Effect of coadministration of nelfinavir, indinavir, and saquinavir on the pharmacokinetics of amprenavirPFISTER, Marc; LABBE, Line; LU, Jian-Feng et al.Clinical pharmacology and therapeutics. 2002, Vol 72, Num 2, pp 133-141, issn 0009-9236Article

Exposure-response relationship of AMG 386 in combination with weekly paclitaxel in recurrent ovarian cancer and its implication for dose selectionLU, Jian-Feng; RASMUSSEN, Erik; KARLAN, Beth Y et al.Cancer chemotherapy and pharmacology. 2012, Vol 69, Num 5, pp 1135-1144, issn 0344-5704, 10 p.Article

Noncorrosive ionic liquids composed of [HSO₄] as esterification catalystsTAO, Duan-Jian; LU, Xue-Ming; LU, Jian-Feng et al.Chemical engineering journal (1996). 2011, Vol 171, Num 3, pp 1333-1339, issn 1385-8947, 7 p.Article

Clinical pharmacokinetics of erlotinib in patients with solid tumors and exposure-safety relationship in patients with non-small cell lung cancerLU, Jian-Feng; EPPLER, Steve M; WOLF, Julie et al.Clinical pharmacology and therapeutics. 2006, Vol 80, Num 2, pp 136-145, issn 0009-9236, 10 p.Article

Betulinic acid ameliorates endothelium-dependent relaxation in L-NAME-induced hypertensive rats by reducing oxidative stressFU, Jia-Yin; QIAN, Ling-Bo; ZHU, Lie-Gang et al.European journal of pharmaceutical sciences. 2011, Vol 44, Num 3, pp 385-391, issn 0928-0987, 7 p.Article

Population pharmacokinetic/pharmacodynamic modeling for the time course of tumor shrinkage by motesanib in thyroid cancer patientsLU, Jian-Feng; CLARET, Laurent; SUTJANDRA, Liviawati et al.Cancer chemotherapy and pharmacology. 2010, Vol 66, Num 6, pp 1151-1158, issn 0344-5704, 8 p.Article